Abstract
According to a common assumption, truthfulness cannot have an intrinsic value in business. Instead, it is considered only instrumentally valuable for business, because it contributes to successful trust-building. Some authors deny truthfulness even this limited role by claiming that truth-telling is not an essential part of business, which is a sui generis practice like poker. In this article, I argue that truthfulness has indeed an intrinsic value in business and identify the conceptual confusions underlying the opposite view. My account of truthfulness as a virtue shows that truthfulness is both valuable for its own sake and instrumental to further valuable goals. It helps pinpoint the implicit contradiction in claiming that truthfulness has an instrumental value only. I then challenge the reasons for considering business exempt from the constraints of truthfulness and elaborate on the analogy between game and business, which in fact supports instead of undermining my claim that business is a truthful practice. Finally, I illustrate my argument with a case study of the current crisis of trust faced by the pharmaceutical industry.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aristotle: 1996, Metaphysics, Loeb Classical Library, vol. 17, 18 (Harvard University Press, Cambridge, MA)
Aristotle: 1982, Nicomachean Ethics, Loeb Classical Library, vol. 19 (Harvard University Press, Cambridge, MA)
Angell M. (2005), The Truth about the Drug Companies: How They Deceive Us and What to Do about It. Random House Trade Paperback, NY
Arrow K. (1984), The Economics of Information. The Belknap Press, Cambridge, MA
Bok S. (1978), Lying: Moral Choice in Public and Private Life. The Harvester Press, Hassocks
Bok S. (1984), Secrets: On the Ethics of Concealment and Revelation. Oxford University Press, Oxford
Carr A.: 1968, ‹Is Business Bluffing Ethical?’, Harvard Business Review, Jan–Feb, pp. 143–153
Dewey J., Tufts J. (1908), Ethics. Holt, Rinehart and Winston, NY
Duska R. (2000), “Business Ethics: Oxymoron or Good Business?”. Business Ethics Quarterly 10(1), 111–129
Frantz S. (2005), “Vioxx Fears Prompt Call for User fee Evaluation”. Drug Discovery 4, 179
Gambetta D. (1988), “Mafia: the Price of Distrust”. In: D. Gambetta (ed), Trust: Making and Breaking Cooperative Relations. Balckwell, Oxford. pp. 158–175
Gevertz N., Amado R. (2004), “Intellectual Property and the Pharmaceutical Industry: A Moral Crossroads Between Health and Property”. Journal of Business Ethics 55, 295–308
Hausman C. (2000), Lies We Live By: Defeating Double-Talk and Deception in Advertising, and the Media. Routledge, NY
Hawthorne F. (2003), The Merck Druggernaut. Wiley, Chichester
Kaiser HealthPoll Report: 2005, (Retrieved August 8, 2006) www.kff.org/healthpollreport
Keep W. (2003), “Adam Smith’s Imperfect Hand: Motivations to Mislead”. Business Ethics: A European Review 12(4), 343–353
Koehn D. (1997), “Business and Game-Playing: The False Analogy”. Journal of Business Ethics 16, 1447–1452
Korsgaard C. (1983), “Two Distinctions in Goodness”, Philosophical Review 91, 27–49
Kramer R., Tylor T. (eds) (1996), Trust in Organisations. SAGE, London
Institute of Medicine: Committee on Implications of For-Profit Enterprise in Health Care: (1986), For-Profit Enterprise in Health Care. National Academy Press, Washington
Lanjouw J. (2003), “Intellectual Property and the Availability of Pharmaceuticals in Poor Countries”. Innovation Policy and the Economy 3, 91–129
Luhman N. (1979), Trust & Power. Wiley, Chichester
MacIntyre A. (1985), After Virtue: A Study on Moral Theory, 2nd ed. Duckworth, London
MacIntyre, A.: 1995, ‹Truthfulness, Lies, and Moral Philosophers: What Can We Learn from Mill and Kant?’, in Tanner Lectures on Human Values, vol. 16 (University of Utah Press, Salt Lake City)
Moynihan R., Heath I., Henry D. (2002), “Selling Sickness: the Pharmaceutical Industry and Disease Mongering”. British Medical Journal 324, 886–891
Radoilska, L. and Scott, D.: 2005, ‹Trust in the Pharmaceutical Industry: A Philosophical Perspective’, (Retreived August 8, 2006). http://www.phil.cam. ac.uk/business/Trust%20in%20the%20Pharmaceutical %20Industry.pdf
Rooner, L.: 2005, ‹Novartis Chief Admits Pharmaceutical Industry Has Lost Public Trust’, The Ethical Corporation, 25.01.2005
Salek S, Edgar A. (eds) (2002), Pharmaceutical Ethics. Wiley, Chichester
Santoro M., Gorrie T. (2005) Ethics and the Pharmaceutical Industry. Cambridge University Press, Cambridge
Serban G. (2001), Lying: Man’s Second Nature. Praeger, Wesport, Conn
Smith R. (2003), “Medical Journals and Pharmaceutical Companies: Uneasy Bedfellows”, British Medical Journal 326, 1202–1205
Stancich, R.: 2003, ‹The Pharmaceutical Industry: A Cross-Section of CR Practice’, The Ethical Corporation, 17.11.2003
Tian K., Keep B. (2002), Customer Fraud and Business Responses. Greenwood Publishing, Westport, CT
Williams B. (1981), “Practical Necessity” in B. Williams, Moral Luck. Cambridge University Press, Cambridge, pp. 124–131
Williams B. (1995), “Moral Incapacity” in B. Williams, Making Sense of Humanity and Other Philosophical Papers. Cambridge University Press, Cambridge, pp. 46–55
Williams B. (2002), Truth and Truthfulness: An Essay in Genealogy. Princeton University Press, Princeton
Author information
Authors and Affiliations
Corresponding author
Additional information
Lubomira Radoilska, PhD., is an Affiliated Lecturer at the Faculty of Philosophy, Cambridge University and a Research Fellow at Clare Hall, Cambridge. Dr Radoilska received her Masters degree in Philosophy from Sofia University and her MPhil and Doctorate from Ecole des Hautes Etudes en Sciences Sociales, Paris. Her research interests fall within the scope of moral philosophy. She has published articles on both theoretical and applied topics.
Rights and permissions
About this article
Cite this article
Radoilska, L. Truthfulness and Business. J Bus Ethics 79, 21–28 (2008). https://doi.org/10.1007/s10551-007-9388-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10551-007-9388-2